Skip to main content

Table 3 Baseline characteristics of the 600 participants in the retrospective cohort study by phenotype

From: Hypertriglyceridemic waist phenotype and risk of chronic kidney disease in community-dwelling adults aged 60 years and older in Tianjin, China: a 7-year cohort study

Variables

Overall

NWNT

EWNT

NWET

HTGW

P value

(n = 600)

(n = 212)

(n = 153)

(n = 74)

(n = 161)

Age (years)

65.82 ± 4.74

66.42 ± 5.21

65.81 ± 4.77

64.95 ± 3.99 *

65.45 ± 4.31

0.078

Male (%)

296 (49.33%)

140 (66.04%)

88 (57.52%)

18 (24.32%) *#

50 (31.06%) *#

< 0.001

BMI (kg/m2)

24.95 ± 3.30

22.56 ± 2.43

26.61 ± 2.64 *

23.27 ± 2.44 *#

27.28 ± 2.58 *#§

< 0.001

WC (cm)

87.01 ± 8.21

80.43 ± 5.64

92.78 ± 5.09 *

80.68 ± 4.42 #

93.08 ± 5.67 *§

< 0.001

SBP (mmHg)

136.33 ± 17.73

134.30 ± 16.98

138.40 ± 15.11*

132.73 ± 22.45 #

138.67 ± 18.14 *§

0.013

DBP (mmHg)

82.24 ± 9.31

81.43 ± 9.97

83.94 ± 8.60 *

80.81 ± 8.44 #

82.35 ± 9.28

0.037

FPG (mmol/L)

5.13 ± 1.04

4.90 ± 0.69

5.26 ± 1.17 *

5.12 ± 1.30

5.31 ± 1.11 *

0.002

TC (mmol/L)

5.19 ± 0.91

5.00 ± 0.87

5.03 ± 0.85

5.49 ± 0.74 *#

5.44 ± 1.00 *#

< 0.001

TG (mmol/L)

1.70 ± 1.08

1.09 ± 0.37

1.21 ± 0.35

2.22 ± 0.63 *#

2.76 ± 1.38 *#

< 0.001

BUN (mmol/L)

5.98 ± 3.00

6.18 ± 2.99

6.23 ± 4.32

5.47 ± 1.65

5.71 ± 1.60

0.142

Scr (mmol/L)

77.17 ± 10.74

78.12 ± 9.87

77.40 ± 12.09

75.58 ± 9.92

76.44 ± 10.78

0.088

eGFR (ml/min/1.73m2)

88.69 ± 12.36

90.59 ± 12.87

90.37 ± 12.64

85.69 ± 10.56 *#

85.97 ± 11.48 *#

< 0.001

ACR (mg/g)

10.60 (6.72 ~ 16.48)

9.04 (5.95 ~ 15.22)

10.20 (6.62 ~ 15.22)

11.90 (7.23 ~ 18.59)

12.66 (7.83 ~ 19.57) *#

0.001

Current smoking (%)

231 (38.50%)

96 (45.28%)

49 (32.03%)

30 (40.54%)

56 (34.78%)

0.049

Current drinking (%)

157 (26.17%)

74 (34.91%)

43 (28.10%)

9 (12.16%) *#

31 (19.25%) *

< 0.001

High-salt diet (%)

230 (38.33%)

76 (35.85%)

61 (39.87%)

31 (41.89%)

62 (38.51%)

0.771

Regular exercise (%)

351 (58.50%)

129 (60.85%)

83 (54.25%)

40 (54.05%)

99 (61.49%)

0.421

Hypertension (%)

317 (52.83%)

89 (41.98%)

84 (54.90%)

40 (54.05%)

104 (64.60%) *

< 0.001

Antihypertensive treatment (%)

311 (51.83%)

87 (41.04%)

82 (53.59%)

39 (52.70%)

103 (63.98%) *

< 0.001

Diabetes (%)

61 (10.17%)

13 (6.13%)

17 (11.11%)

8 (10.81%)

23 (14.29%)

0.062

Antidiabetic therapy (%)

55 (9.17%)

12 (5.66%)

13 (8.50%)

8 (10.81%)

22 (13.66%)

0.058

  1. Abbreviations: NWNT Normal waist-normal triglycerides; EWNT Elevated waist-normal triglycerides; NWET Normal waist-elevated triglycerides; HTGW Hypertriglyceridemic waist; BMI Body mass index; WC Waist circumference; SBP Systolic blood pressure; DBP Diastolic blood pressure; FPG Fasting plasma glucose; TC Total cholesterol; TG Triglycerides; BUN Blood urea nitrogen; Scr Serum creatinine; eGFR Estimated glomerular filtration rate; ACR Albumin-to-creatinine ratio
  2. Data are expressed as the mean ± standard deviation, median (interquartile range), or frequency (percentage).
  3. P values were calculated using one-way analysis of variance or non-parametric tests for continuous variables and the chi-square test for categorical variables.
  4. * Compared with the NWNT group, P < 0.05
  5. # Compared with the EWNT group, P < 0.05
  6. § Compared with the NWET group, P < 0.05
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us